NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC)

CUSIP: 65343E207

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
+187,315
SEC-reported price per share
$10.68
Number of holders
26
Value change
+$1,884,758
Number of buys
8
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,572,272

Security key

65343E207

Report period

Q1 2026

Institutions

26

Top holders

10

Ownership snapshot

Top reported holders of NXTC - NextCure, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Simcere Zaiming, Inc.
Disclosed value leader
Affinity Asset Advisors, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 9.4% 13D/G row: Simcere Zaiming, Inc. Showing 1-6 of 15 holder rows.

Quick read

Simcere Zaiming, Inc. leads the comparable SEC ownership view at 9.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Simcere Zaiming, Inc.'s linked filing trail.
Comparable ownership Top 5
Simcere Zaiming, Inc. 9.4%
Sofinnova Venture Partners IX, L.P. 7.1%
SILVERARC CAPITAL MANAGEMENT, LLC 5%
CITIGROUP INC 4.3%
PFIZER INC 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Simcere Zaiming, Inc.
13D/G
9.4%
$152,386
338,636 shares
$0 31 Dec 2025
Sofinnova Venture Partners IX, L.P.
13D/G
Sofinnova Venture Partners IX, L.P. ("SVP IX")
7.1%
$2,947,939
222,654 shares
$0 19 Dec 2025
SILVERARC CAPITAL MANAGEMENT, LLC
13F 13D/G
Company
5%
from 13D/G
$2,498,249
176,057 shares
31 Dec 2025
CITIGROUP INC
13D/G
Citigroup Global Markets Inc.
4.3%
$506,181
1,205,193 shares
$0 31 Mar 2025
PFIZER INC
13F 13D/G
Company · Pfizer Inc. (IRS Identification No.: 13-5315170)
3%
from 13D/G
$2,236,997
157,646 shares
31 Dec 2025
Affinity Asset Advisors, LLC
13F
Company
13F
5.4%
$3,509,102
247,294 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
26
Shares
2,169,454
Rows available
26
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
24
Q1 2026 holders
26
Holder diff
2
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .